In the present study, we found that FABP4 level is associated with clinical parameters of obesity, insulin resistance, dyslipidemia, and high blood pressure even in asymptomatic apparently healthy subjects with no pharmacological treatments. This evidence concerns the gene FABP4 and obesity due to melanocortin 4 receptor deficiency.